Jimmy Carter’s Melanoma drug on the verge of ?breakthrough?

Jimmy Carter (18 May 2016)In 2014, FDA gave pembrolizumab accelerated approval for melanoma.?

Today, the 3-year survival rate in melanoma patients is reported to be 40%.? ASCO president Dr. Julie Vose told NBC News, “This is something really different than what we have seen in the past.” ? via ? @3SixtyPharma

Leave a Reply

Your email address will not be published.

%d bloggers like this: